Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$0.95 USD
-0.03 (-3.53%)
Updated May 14, 2024 04:00 PM ET
After-Market: $0.95 0.00 (0.26%) 6:44 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Earnings News For RIGL
-
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates
-
Rigel: Q1 Earnings Snapshot
-
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
-
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?
-
Rigel: Q3 Earnings Snapshot
-
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
-
Rigel: Q2 Earnings Snapshot
-
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates
-
Rigel: Q1 Earnings Snapshot
-
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Rigel: Q4 Earnings Snapshot
-
Rigel Pharmaceuticals (RIGL) Q4 Earnings and Revenues Surpass Estimates
-
Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Lags Revenue Estimates
-
Rigel: Q3 Earnings Snapshot
-
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates
-
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Misses Revenue Estimates
-
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates